Jemma Arakelyan: Discussing interdisciplinary approach to cancer research
Jemma Arakelyan, Medical Oncologist and the Chief Executive Officer of The Institute of Cancer and Crisis, shared a post on LinkedIn:
“Connecting with like-minded individuals passionate about an interdisciplinary approach to cancer research.
Our discussions focused on bridging the gap between academia and clinical practice, all with the ultimate goal of benefiting patients.
Exciting developments are on the horizon, and I can’t wait to share more soon.
A special thank you to Dr. William Cho and Dr. Ken for your contributions and insights.”
Dr. Jemma Arakelyan is a medical oncologist and the Chief Executive Officer of The Institute of Cancer and Crisis. Under her leadership, the Institute is dedicated to raising awareness and providing support for cancer patients facing critical challenges, including those arising from war and pandemics. Currently, she is pursuing her Ph.D. at the City University of Hong Kong, focusing on the development of new anticancer treatments and the mechanisms driving cancer progression. In addition to her academic work, Dr. Arakelyan is actively involved in several scientific organizations, including the European School of Oncology (ESO), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). She also serves as an advisor at the Immune Oncology Research Institute, where they work closely on the clinical development of novel immunotherapeutic agents.
More posts featuring Jemma Arakelyan.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023